JW Therapeutics, a China cancer treatment specialist established by Bristol Myers Squibb-owned Juno Therapeutics and China’s WuXi AppTec, has received $100 million in Series B funding.
The round was led by CPE – formerly CITIC Private Equity – and Mirae Asset. Additional commitments came from Oriza Holdings and CR-CP Life Science Fund, a $300 million life sciences vehicle established...
The Riverside Group has bought Australian injury management and occupational rehabilitation services provider Nabenet as part of a workplace wellbeing rollup strategy.
Dreame, a Beijing-headquartered vacuum cleaner maker backed by smart phone and consumer electronics giant Xiaomi, has raised RMB3.6 billion ($563 million) in Series C funding.
Primavera Capital Group has invested $600 million in two subsidiaries of Envision Group, a China-based manufacturer of wind turbines, smart batteries, and renewable energy management systems.
India’s Axis Bank has launched a distress buyout fund targeting INR35 billion ($468 million) via its asset management business.